Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol to Reduce Perioperative Myocardial Injury
NCT03138603Phase 3Completed
- Sponsor
- University of Chicago
- Start
- Dec 2016
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Myocardial injury comparing Metoprolol with Placebo (2 arms). Primary endpoint: Effectiveness of Beta-blocker Therapy Reducing Post-operative Myocardial Injury. Started Dec 2016; status: completed.
02
Drugs
metoprolol
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on NCT03138603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03138603.